Parsons Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Sell
32,692
-40,000
-55% -$146K 0.01% 517
2026
Q1
$287K Sell
72,692
-2,582
-3% -$13K 0.01% 425
2025
Q4
$510K Sell
75,274
-21,500
-22% -$151K 0.03% 323
2025
Q3
$675K Sell
96,774
-45,000
-32% -$313K 0.04% 284
2025
Q2
$866K Sell
141,774
-4,875
-3% -$32.4K 0.05% 259
2025
Q1
$1.11M Sell
146,649
-20,500
-12% -$171K 0.06% 238
2024
Q4
$1.61M Sell
167,149
-23,497
-12% -$183K 0.09% 188
2024
Q3
$1.13M Sell
190,646
-26,500
-12% -$176K 0.07% 223
2024
Q2
$1.5M Sell
217,146
-10,000
-4% -$70.3K 0.1% 181
2024
Q1
$1.75M Hold
227,146
0.12% 165
2023
Q4
$1.99M Hold
227,146
0.14% 149
2023
Q3
$1.66M Sell
227,146
-30,359
-12% -$226K 0.13% 154
2023
Q2
$1.7M Sell
257,505
-136,700
-35% -$697K 0.13% 155
2023
Q1
$1.34M Sell
394,205
-5,630
-1% -$21.8K 0.11% 174
2022
Q4
$1.11M Sell
399,835
-225,625
-36% -$675K 0.09% 191
2022
Q3
$1.79M Sell
625,460
-18,662
-3% -$66.3K 0.16% 129
2022
Q2
$2.23M Sell
644,122
-51,159
-7% -$200K 0.2% 110
2022
Q1
$3.27M Sell
695,281
-8,500
-1% -$41.6K 0.25% 92
2021
Q4
$4.25M Sell
703,781
-32,226
-4% -$224K 0.3% 75
2021
Q3
$4.46M Sell
736,007
-56,783
-7% -$640K 0.35% 68
2021
Q2
$9.92M Sell
792,790
-28,697
-3% -$311K 0.76% 24
2021
Q1
$8.46M Sell
821,487
-50,000
-6% -$483K 0.69% 27
2020
Q4
$7.91M Buy
+871,487
New +$6.27M 0.68% 29
2018
Q4
Sell
-492,720
Closed -$3.04M 348
2018
Q3
$3.04M Buy
492,720
+8,810
+2% +$39.8K 0.32% 80
2018
Q2
$3.09M Buy
483,910
+14,273
+3% +$102K 0.35% 76
2018
Q1
$3.27M Buy
469,637
+56,485
+14% +$658K 0.38% 68
2017
Q4
$5.21M Buy
413,152
+56
+0% +$683 0.58% 39
2017
Q3
$4.91M Buy
413,096
+469
+0.1% +$6.96K 0.58% 41
2017
Q2
$6.18M Sell
412,627
-206,173
-33% -$2.75M 0.75% 30
2017
Q1
$5.9M Sell
618,800
-103,500
-14% -$874K 0.75% 31
2016
Q4
$6.4M Sell
722,300
-5,000
-0.7% -$44.9K 0.85% 24
2016
Q3
$6.24M Buy
727,300
+50
+0% +$396 0.84% 28
2016
Q2
$5.8M Buy
727,250
+2,550
+0.4% +$19.8K 0.79% 29
2016
Q1
$6.33M Buy
724,700
+6,000
+0.8% +$49.9K 0.87% 23
2015
Q4
$6.73M Buy
718,700
+10,650
+2% +$92.3K 0.95% 17
2015
Q3
$6.83M Sell
708,050
-5,250
-0.7% -$55.4K 1% 14
2015
Q2
$8.27M Buy
713,300
+3,150
+0.4% +$32.4K 1.1% 13
2015
Q1
$7.39M Sell
710,150
-4,799
-0.7% -$44.9K 1.04% 13
2014
Q4
$8.24M Sell
714,949
-9,400
-1% -$92.9K 1.09% 14
2014
Q3
$5.17M Buy
724,349
+2,000
+0.3% +$13.9K 0.71% 30
2014
Q2
$5.12M Sell
722,349
-12,500
-2% -$73.2K 0.7% 33
2014
Q1
$4.5M Buy
734,849
+35,850
+5% +$263K 0.64% 39
2013
Q4
$6.11M Buy
698,999
+2,400
+0.3% +$14.7K 0.92% 20
2013
Q3
$2.9M Sell
696,599
-2,900
-0.4% -$16K 0.48% 54
2013
Q2
$4.94M Buy
+699,499
New +$4.89M 0.85% 26

Other funds holding MDXG

Parsons Capital Management's MDXG Position: Q2 2026 in Review

Parsons Capital Management reduced its MiMedx Group (MDXG) stake by 55% in Q2 2026, selling an estimated $146K and leaving 32,692 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #517.

Parsons Capital Management first reported a position in MDXG in Q2 2013 and has held it in 45 quarters since. The position peaked at $9.92M in Q2 2021. 47 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Parsons Capital Management held 32,692 shares of MiMedx Group worth $126K as of Q2 2026.
  • Parsons Capital Management sold 40,000 MiMedx Group shares in Q2 2026, an estimated $146K.
  • MiMedx Group made up 0.01% of Parsons Capital Management's portfolio in Q2 2026, its #517 holding.
  • Parsons Capital Management first reported a position in MiMedx Group in Q2 2013 and has held it in 45 quarters since.
  • Parsons Capital Management's MiMedx Group position peaked at $9.92M in Q2 2021.
  • 47 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.